Cardiovascular Systems Stock Price

-0.37 (-0.93%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cardiovascular Systems Inc CSII NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.37 -0.93% 39.53 18:00:11
Open Price Low Price High Price Close Price Prev Close
40.13 39.36 40.13 39.53 39.90
Bid Price Ask Price Spread News
38.25 54.50 16.25 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,675 59,141 $ 39.64 $ 2,344,099 224,139 27.70 - 48.28
Last Trade Time Type Quantity Stock Price Currency
16:05:13 76 $ 39.53 USD

Cardiovascular Systems Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.59B 40.16M 27.64M $ 236.55M $ -24.84M -0.79 -61.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 4.27k 9.30%

more financials information »

Cardiovascular Systems News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CSII Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week37.3740.1337.0539.0592,1502.165.78%
1 Month35.8240.1335.1138.11207,5853.7110.36%
3 Months40.0642.0234.0738.10206,181-0.53-1.32%
6 Months37.7148.2834.0740.78218,5541.824.83%
1 Year32.7548.2827.7036.55274,3766.7820.7%
3 Years29.7555.217324.8438.26297,6669.7832.87%
5 Years18.2855.217316.5733.59288,05521.25116.25%

Cardiovascular Systems Description

Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generates the vast majority of its revenue in the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.